Mar 23, 2022 / 01:00PM GMT
Peter Keeling - Diaceutics PLC - Founder, CEO & Executive Director
Hello, everybody, and welcome to Diaceutics' 2021 Full Year Results. I'm looking forward to talking to you about the transformation that has been taking place in our business over the past 12 months. But before I start, let me introduce our new Chief Financial Officer, Nick Roberts. Nick has been -- joined the company only past Friday, but has been working with myself and the outgoing CFO for the [fight] to transition into the role. Nick, talk about yourself.
Nicholas Stewart Roberts - Diaceutics PLC - CFO & Director
Thank you, Peter. Firstly, can I say I'm delighted to have joined Diaceutics. It's such an exciting time in its growth journey. A bit about me. I'm a fellow chartered accountant with over 16 years' experience. I originally trained with Baker Tilly, now RSM, in their audit department where I eventually moved up to the position of Audit Manager before deciding to move into industry.
Over the past 7 years, I've been fortunate enough to work with high-growth AIM-listed
Full Year 2021 Diaceutics PLC Earnings Call Transcript
Mar 02, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers